Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 known ✓ | O75116 | 1/20 | 0.36 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL641559 | 0.98 | MAPK1 (0.46) | MAPK1ABCB1CDC7ROCK2MAP4K4 | |
| SCHEMBL12322236 | 0.79 | QPCT (0.38) | MAPK1ABCB1CDC7 | |
| SCHEMBL1622388 | 0.79 | DHFR (0.32) | MAPK1ABCB1 | |
| SCHEMBL1622467 | 0.79 | MAPK1 (0.32) | MAPK1SMN1; SMN2 | |
| SCHEMBL13982529 | 0.78 | CDK8 (0.40) | MAPK1MAP4K4CLK4LIMK1ALDH1A1 | |
| SCHEMBL12322232 | 0.78 | MAPK1 (0.31) | MAPK1L3MBTL1 | |
| SCHEMBL1621900 | 0.78 | BCAT2 (0.41) | L3MBTL1ALDH1A1KDM4ELMNAGAA | |
| SCHEMBL12310607 | 0.78 | MAPK1 (0.31) | MAPK1GAA | |
| SCHEMBL641950 | 0.77 | ABCB1 (0.40) | MAPK1ABCB1CDC7ROCK2MAP4K4 | |
| SCHEMBL14767743 | 0.77 | MAPK1 (0.42) | MAPK1CDC7ROCK2MAP4K4PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2247196-B1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX INC (US) | 2014-11-26 | — | — | EP | claimed |
| US-8440676-B2 | Sweetener compositions and methods of making them | SENOMYX, INC. (US) | 2013-05-14 | — | — | US | claimed |
| US-20120177584-A1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX, INC. (US) | 2012-07-12 | — | — | US | claimed |
| EP-2247196-A2 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | Senomyx, Inc. (US) | 2010-11-10 | — | — | EP | claimed |
| US-20090292010-A1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX, INC. | 2009-11-26 | — | — | US | claimed |
| WO-2009100333-A2 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX, INC. (US) | 2009-08-13 | — | — | WO | claimed |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| CN-119894387-A | Flavor modulating composition | 玉米产品开发公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250081996-A1 | FLAVOR MODIFYING COMPOSITION | PURECIRCLE SDN BHD (MY) | 2025-03-13 | — | — | US | disclosed |
| CN-117835831-A | Flavor modulating composition | 玉米产品开发公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| CN-114739975-A | SERS substrate with gold and silver array structure and preparation method and application thereof | 中山大学 | 2022-07-12 | — | — | CN | disclosed |
| US-8119821-B2 | Sweetener compositions and methods of making them | SENOMYX, INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110224155-A1 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | SENOMYX INC. (US) | 2011-09-15 | — | — | US | disclosed |
| EP-2247196-A2 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | Senomyx, Inc. (US) | 2010-11-10 | — | — | EP | disclosed |
| US-20090292010-A1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX, INC. | 2009-11-26 | — | — | US | disclosed |
| WO-2009100333-A2 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SENOMYX, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| EP-2062050-A2 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | Senomyx, Inc. (US) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008154221-A2 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | SENOMYX, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | ROCK2 4827/4885GAA 303/4885MAPK1 1556/4885 |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | ROCK2 2035/4885GAA 336/4885MAPK1 2601/4885 |
| US-20120177584-A1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SI, TAS2R5, TASP1 | ROCK2 4876/4885GAA 1140/4885MAPK1 4548/4885 |
| US-20110224155-A1 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | TAS2R30, TAS2R50, TAS2R1 | ROCK2 4724/4885GAA 3792/4885MAPK1 3358/4885 |
| US-20090292010-A1 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THEM | SI, TAS2R5, TASP1 | ROCK2 4876/4885GAA 1140/4885MAPK1 4548/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | ROCK2 4827/4885GAA 303/4885MAPK1 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.